4th Edition of International Conference on Probiotics and Prebiotics
March 26-28, 2026
AI in Probiotic Research
AI in probiotic research is enabling significant breakthroughs in the understanding and application of probiotics. Through data mining and predictive analytics, AI algorithms can identify patterns in microbiome compositions that contribute to health benefits, guiding the selection of effective probiotic strains. Additionally, AI-driven technologies streamline the process of fermentation and production by predicting optimal growth conditions for probiotic microorganisms. The integration of AI in research also facilitates real-time monitoring of clinical trials, enabling faster and more accurate assessments of probiotic efficacy. With AI’s capacity to process large datasets and model complex biological systems, the future of probiotic research promises more targeted and individualized probiotic therapies, enhancing their potential in disease prevention and treatment.
Dipak P Ramji
Cardiff University, United Kingdom
Giuseppinella Melita
University of Study Messina, Italy
Jason Ryan
Sacco System, Australia
Najat Amharar
Burjeel, United Arab Emirates
Hazal Kibar Demirhan
Ankara University, Turkey
Euller Fernandes Lopes
University of Brasília, Brazil
Veronica Donato
Northeastern University, United StatesSubmit your abstract Today
Title : Overcoming manufacturing challenges in next-generation probiotics: From anaerobic cultivation to clinical-grade formulation
Jason Ryan, Sacco System, Australia
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: State-of-the-art and new insights
Giuseppinella Melita, University of Study Messina, Italy
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Potential for prebiotic food supplement production from by-products of dried persimmon (Diospyros kaki)
Yasin Ozdemir, Ataturk Horticultural Central Research Institute, Turkey